Tennessee Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tennessee Healthcare Today.

Press releases published on August 27, 2026

ICU Medical to Participate in Upcoming Investor Conferences
Mental Health America announces Dr. Tia Dole as new president and CEO
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
Biomerica Announces $2.23 Million Financing 
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights
Alvotech to present at upcoming investor conferences in September
Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
Artelo Biosciences Announces Reverse Stock Split
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany
Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
Entera to Participate in Upcoming Fall Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tennessee Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.